Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbonate in Participants With Central Nervous System Tumors

Not Recruiting

Trial ID: NCT03565367


This early phase I trial studies how well hyperpolarized carbon C 13 pyruvate magnetic resonance imaging works in detecting lactate and bicarbonate in participants with central nervous system tumors. Hyperpolarized carbon C 13 pyruvate magnetic resonance imaging may be used to measure the metabolic state of malignant brain tumors.

Official Title

A Pilot Study to Assess Lactate and Bicarbonate Detection Within Malignant Brain Tumors Using [1-13C]-Pyruvate DNP Magnetic Resonance Spectroscopy (MRS)

Stanford Investigator(s)

Reena Thomas, MD PhD
Reena Thomas, MD PhD

Clinical Associate Professor, Neurology & Neurological Sciences Clinical Associate Professor (By courtesy), Neurosurgery


Inclusion Criteria:

   - Patients with a known diagnosis of central nervous system (CNS) malignancy, including
   metastases, with known enhancement on magnetic resonance (MR) who are otherwise
   eligible to undergo MRI

   - Glomerular filtration rate (GFR) > 30 ml/min

   - No allergy to gadolinium

   - Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

   - Refusal to have an IV placed for injection

   - Acute major illness (e.g., unstable angina, etc.) or other condition that makes
   participation unsafe, per the investigator?s judgement

   - Total bilirubin > 1.5 x upper limit of normal (ULN)

   - Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) > 2.5 x ULN

   - Gamma-glutamyltransferase (GGT) > 2.5 x ULN

   - Pregnant or breast-feeding

   - Cardiovascular risk, including:

      - Poorly controlled hypertension, defined as either systolic > 170 or diastolic >

      - Congestive heart failure

      - Myocardial infarction within the past year

      - QT prolongation, defined as pretreatment corrected QT interval (QTc) > 440 msec
      in males or > 460 msec in females


other: Gadolinium

drug: Hyperpolarized Carbon C 13 Pyruvate

procedure: Magnetic Resonance Imaging

procedure: Magnetic Resonance Spectroscopic Imaging

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Lewis Naya

New Trial Alerts

Receive email alerts when trials open to patients.